Market Place
Sourcing Support
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
Top Biotech and Pharma Deals in April 2018
Insofar as pharma M&As are concerned, 2018 is turning out to be a milestone year with more than
